Clinical Trials Research Alliance (CTRA)

Standardized Treatment of Pulmonary Exacerbations II (STOP2)

About this Trial

This randomized, controlled, open-label study is designed to evaluate the efficacy and safety of differing durations of IV treatment, given in the hospital or at home for a pulmonary exacerbation in adult patients with CF.

  • Status: Enrolling now
  • Location: Miami Valley Hospital
  • Study type: Interventional
  • Ages eligible for study: 18 and older
  • Genders eligible for study: Both
  • Principal Investigator: Hari, Polenakovik, MD
  • For more information about this study, visit NCT02781610

Contact us

If you would like information about participating in this study, contact:

Linda Clark
(937) 208-2913

Last edited on 01/11/2019.